Latest news for CompuGroup Medical (OTC:CMPUY) Stock

CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through four segments: Ambulatory information systems, Pharmacy information systems, Hospital information systems, and Consumer and Health Management Information Systems. The Ambulatory information systems segment contributes to the majority of revenue and provides practice management software and electronic medical record management. Pharmacy information systems provide clinical, administrative, and financial software for retail pharmacies. The Hospital information systems segment sells its solutions to in-patient centers. Consumer and Health Management Information Systems offers networking service connect providers and other market participants.

Financial,Analyst,Using,Smartphone,With,Real-time,Stocks,,Commodities,And,Market

Equities

News

Global

Markets

CMPUY

EXNWF

The investment banking giant, Morgan Stanley, has singled out three globally underappreciated tech stocks that it believes hold substantial growth potential.

Morgan Stanley&#39;s Hidden Gems: 3 Underappreciated Tech Stocks Set To Surge

COMPUGROUP MED SE&CO ADR by CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co KgaA

CompuGroup Medical SE & Co. KGaA goes ex dividend tomorrow

CompuGroup Medical

The investment banking giant Morgan Stanley has singled out three globally underappreciated tech stocks that it believes hold substantial growth potential.



What Happened: Morgan Stanley has identified CompuGroup Medical (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CMPUY#OTC">CMPUY</a>), a healthcare software provider, Exclusive Networks (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EXNWF#OTC">EXNWF</a>), a cybersecurity firm, and W.A.G. Payment Solutions as overlooked stocks with attractive valuations. The bank has assigned an overweight rating to all three, <a href="https://www.cnbc.com/2024/04/08/morgan-stanley-names-3-overlooked-global-tech-stocks-to-buy.html">reported</a> CNBC.



&nbsp;"As this theme of ‘broadening out' becomes more important, we think investors will increasingly look to quality small caps at attractive valuations as sources of alpha," said Morgan Stanley.



"CGM benefits from the typical attributes of the software business model e.g. high customer stickiness given the high switching costs, highly recurring revenue (~70%) providing high visibility, the ability to put through annual price increases, healthy margins which should be boosted by operating leverage and price increases, and healthy [free cash flow] generation," the analysts wrote.



The bank views CompuGroup, which holds leading market positions in several countries, including Germany, France, and Austria, as the most undervalued stock in its software coverage. Morgan Stanley has set a price target of 37 euros for CompuGroup, suggesting a 23% upside.



W.A.G. Payment Solutions, a prominent integrated payment provider, was also tagged as an undervalued stock with a price target of 135 pence, indicating a 98.5% upside.



See Also: <a href="https://www.benzinga.com/partner/cryptocurrency/24/04/38043114/crypto-lending-101-making-the-most-of-your-idle-digital-assets?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Crypto Lending 101: Making The Most Of Your Idle Digital Assets</a>



Exclusive Networks, one of the largest and fastest-growing specialist distributors of cybersecurity products globally, was assigned a price target of 26.5 euros, a 15.7% upside from its current price.



&nbsp;"We continue to view Exclusive as an attractive way for European investors to play the theme of cybersecurity in a diversified manner," the bank said.



Why It Matters: The stock market has been on a bull run, with some analysts predicting that it&#8217;s only halfway through its potential, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37382670/stock-market-bull-rally-only-halfway-through-could-continue-until-2027-ned-davis-re">according to a report</a> from Ned Davis Research (NDR) in February. However, other analysts have warned of a potential market correction, as stocks are running out of reasons to move higher, <a href="https://www.benzinga.com/markets/equities/24/02/37078037/market-correction-due-stocks-are-running-out-of-reasons-to-move-higher-analyst-says">as per a report</a> by Piper Sandler in the same month.



In March, Bank of America predicted that the stock market&#8217;s <a href="https://www.benzinga.com/markets/equities/24/03/37926504/stock-market-could-rally-another-34-by-2026-says-bank-of-america">long-term bull rally</a> could continue, with the S&amp;P 500 potentially surging by 34% by the end of 2026. However, another leading research firm warned that <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37640416/stock-market-could-be-on-brink-of-a-correction-says-analyst-who-doesnt-expect-a-bea">global stock markets</a> might be on the brink of a correction.



Morgan Stanley&#8217;s identification of these overlooked tech stocks in this volatile market scenario could provide investors with potential growth opportunities.



Read Next: <a href="https://www.benzinga.com/markets/equities/24/04/38131375/trump-is-expected-to-raise-43-million-in-fundraising-event-but-is-missing-support-from-one-key-d?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Is Expected To Raise $43 Million In Fundraising Event But Is Missing Support From One Key Donor Who Fueled 2020 Campaign</a>



Image Via Shutterstock 



<div style="font-family: 'Lato', sans-serif">
 <div>
 <hr style="border: 0;height: 5px;background: #225aa9">
 <div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>
 
 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/kaustubh-bagalkote" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Kaustubh Bagalkote</a>
 
 
 <hr style="border: 0;height: 1px;background: #225aa9">
 
 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
 <hr style="border: 0;height: 5px;background: #225aa9">
 </div>
</div>

Comments

CompuGroup Medical

News

Latest news for CompuGroup Medical (OTC:CMPUY) Stock

Monday, April 08, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga